Clinical Trials in New York

Showing 5301-5320 of 17,259 trials

Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System

NCT02514525

To evaluate the efficacy and safety of the CryoBalloon Focal Ablation System for the treatment of previously-untreated ("treatment naïve") Barrett's Esophagus (BE)

Barrett Esophagus

Pentax Medical150 participantsStarted Mar 2016

Orange, California, United States • Sarasota, Florida, United States • Chicago, Illinois, United States +8 more locations

COMPLETED< 1 mile

Glucose Monitoring During Chemotherapy

NCT04473378

This is a research study to look at blood sugar changes during chemotherapy using a continuous blood sugar monitoring device. The device uses patches that attach to the skin on the back of the arm to measure blood sugar changes for the duration of the chemotherapy course. Each patch lasts for about 2-weeks. During chemotherapy visits, new patches will be placed and will be worn until the chemotherapy course is complete. Participants will be in this study for 6 months. Approximately 50 patients will be enrolled in this study.

Breast CancerHyperglycemia

Columbia University22 participantsStarted Oct 2019

New York, New York, United States

Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System

Glucose Monitoring During Chemotherapy

Find Trials by Condition in New York

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

Emergency Department-Initiated Buprenorphine Validation Network Trial

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation

Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma

Computer-based Intervention for Alcohol-using HIV/HCV+ Women

A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response

Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth In/near Infected Bone Cavities

AZD9291 (Osimertinib) Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Benefits of Microcor in Ambulatory Decompensated Heart Failure

EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

Benefits of µCor in Ambulatory Decompensated Heart Failure

Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

Prophylactic vs Therapeutic Cerebrospinal Fluid Drain Placement During Endovascular Thoracoabdominal Aortic Aneurysm Repair

A Study of TAK-861 in Participants With Narcolepsy Type 2

Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis